AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Director's Dealing 2024

Aug 13, 2024

1643_dirs_2024-08-13_336acbbd-02f3-4f79-9ccf-218f8f1ee788.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MeiraGTx Holdings plc (MGTX)
CIK: 0001735438
Period of Report: 2024-08-12

Reporting Person: Sanofi (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares ($0.00003881 par value per share)	11500000	Indirect
Ordinary Shares ($0.00003881 par value per share)	697737	Indirect

Footnotes

F1: Sanofi is the beneficial owner of Ordinary Shares of the Issuer through its wholly owned subsidiaries Sanofi Foreign Participations B.V. and Kadmon Corporation, LLC.